Nigeria: NCDC Reports Three New Lassa Fever Cases in Edo, Ondo

3 September 2025
Vanguard (Lagos)
By Joseph Erunke

The Nigeria Centre for Disease Control and Prevention, NCDC, has released its Lassa Fever Situation Report for Week 34 (August 18-24, 2025), confirming three new cases in Edo and Ondo states.

The figure represents a decline from five cases recorded in the previous week.

According to the report, the cumulative total for 2025 has risen to 857 confirmed cases and 160 deaths, with a case fatality rate (CFR) of 18.7 percent. This marks an increase compared to the 17.1 percent CFR recorded during the same period in 2024.

So far, 21 states have reported at least one confirmed case across 106 local government areas.

NCDC noted that 90 percent of the confirmed cases originated from Ondo, Bauchi, Edo, Taraba and Ebonyi states.

The centre further disclosed that the predominant age group affected remains 21-30 years, while no new healthcare worker infections were recorded in the reporting week.

It added that both suspected and confirmed cases of Lassa fever have shown a downward trend compared to the same period in 2024.

Read the original article on Vanguard.

Tagged:
Copyright © 2025 Vanguard. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 600 reports a day from more than 90 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.